Literature DB >> 3499164

Do phenothiazines contribute to tumour regressions in lymphokine-activated killer cell/interleukin-2 treatments of renal cell cancer?

C Sauter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3499164      PMCID： PMC2002135          DOI： 10.1038/bjc.1987.182

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

1.  Effect of reserpine and chlorpromazine on sarcoma 37.

Authors:  M BELKIN; W G HARDY
Journal:  Science       Date:  1957-02-08       Impact factor: 47.728

2.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Authors:  S A Rosenberg; M T Lotze; L M Muul; S Leitman; A E Chang; S E Ettinghausen; Y L Matory; J M Skibber; E Shiloni; J T Vetto
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

3.  Chlorpromazine distribution in hamsters and mice bearing transplantable melanoma.

Authors:  R G Fairchild; D Greenberg; K P Watts; S Packer; H L Atkins; P Som; S J Hannon; A B Brill; I Fand; W P McNally
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

4.  Effect of antiparkinsonian medication on plasma levels of chlorpromazine.

Authors:  G M Simpson; T B Cooper; N Bark; I Sud; J H Lee
Journal:  Arch Gen Psychiatry       Date:  1980-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.